Literature DB >> 3677104

Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.

M J Mattes1, K Look, K Furukawa, V K Pierce, L J Old, J L Lewis, K O Lloyd.   

Abstract

Four different human epithelial differentiation antigens (MT179, MW162, MW207, and MX35) have been defined by mouse monoclonal antibodies obtained from mice immunized with either an ovarian carcinoma cell line or fresh ovarian carcinoma cells. In an attempt to identify tissue-specific antigens restricted to ovarian epithelial cells, sections of a benign ovarian cyst were used as the initial target for screening hybridoma supernatants. The distribution of the antigens detected by these monoclonal antibodies was determined on frozen sections of 24 normal tissues and on 103 cultured cell lines of various histological types. In spite of the method used to select these monoclonal antibodies, they all reacted to some degree with normal epithelial cells in tissues other than ovary. All antibodies were unreactive with nonepithelial cells in frozen sections. These antibodies also reacted with frozen sections of most or all fresh ovarian carcinomas and benign ovarian cysts. All antibodies were unreactive with ABH, Lewis blood group-related antigens and appeared to be different in specificity from previously described well-characterized antigens of ovarian carcinoma cells. MW162 was characterized as a high-molecular-weight mucin-like molecule, and the determinant recognized is probably carbohydrate in nature. MW207 was identified as a Mr 37,000 protein. These monoclonal antibodies and 24 other previously derived antibodies that react with epithelial differentiation antigens were tested for reactivity with the surface of fresh ovarian carcinoma ascites cells and for nonreactivity with normal mesothelial cells. This assay was designed to select monoclonal antibodies that might be effective agents for i.p. therapy or radioimmunodetection of human ovarian carcinoma. Five antibodies with the desired specificity were selected; these were the four new antibodies described herein and MH99, which was characterized previously and recognizes a glycoprotein having Mr 38,000 and 29,000 subunits. The degree of heterogeneity of antigen expression on ascites carcinoma cell was dependent on the particular antigen being examined and was related to the biochemical nature of the antigen. In particular, most ABH and Lewis blood group-related antigens showed a striking degree of heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3677104

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Characterization of four novel epithelial ovarian cancer cell lines.

Authors:  D M Provencher; H Lounis; L Champoux; M Tétrault; E N Manderson; J C Wang; P Eydoux; R Savoie; P N Tonin; A M Mes-Masson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-06       Impact factor: 2.416

2.  Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas.

Authors:  Beatrice W T Yin; Ramziya Kiyamova; Ramon Chua; Otavia L Caballero; Ivan Gout; Vitalina Gryshkova; Nimesh Bhaskaran; Serhiy Souchelnytskyi; Ulf Hellman; Valeriy Filonenko; Achim A Jungbluth; Kunle Odunsi; Kenneth O Lloyd; Lloyd J Old; Gerd Ritter
Journal:  Cancer Immun       Date:  2008-02-06

3.  Identification of tumor-associated antigens from medullary breast carcinoma by a modified SEREX approach.

Authors:  Ramziya Kiyamova; Olga Kostianets; Sergey Malyuchik; Valeriy Filonenko; Vasiliy Usenko; Vadym Gurtovyy; Yuliya Khozayenko; Stepan Antonuk; Lloyd Old; Ivan Gout
Journal:  Mol Biotechnol       Date:  2010-10       Impact factor: 2.695

4.  Binding parameters of monoclonal antibodies reacting with ovarian carcinoma ascites cells.

Authors:  M J Mattes; K O Lloyd; J L Lewis
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  The human hair follicle: glycoprotein-related antigenic profile of distinct keratinocyte populations in vivo and their alterations in vitro.

Authors:  M P Schön; U Blume-Peytavi; M Schön; C E Orfanos
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

6.  14C1, an antigen associated with human ovarian cancer, defined using a human IgG monoclonal antibody.

Authors:  G Gallagher; F al-Azzawi; L P Walsh; G Wilson
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

7.  Intraperitoneal α-Emitting Radioimmunotherapy with 211At in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose Estimations.

Authors:  Andreas Hallqvist; Karin Bergmark; Tom Bäck; Håkan Andersson; Pernilla Dahm-Kähler; Mia Johansson; Sture Lindegren; Holger Jensen; Lars Jacobsson; Ragnar Hultborn; Stig Palm; Per Albertsson
Journal:  J Nucl Med       Date:  2019-01-25       Impact factor: 10.057

8.  HNRNPC as a candidate biomarker for chemoresistance in gastric cancer.

Authors:  Hao Huang; Yong Han; Cheng Zhang; Jian Wu; Junnan Feng; Like Qu; Chengchao Shou
Journal:  Tumour Biol       Date:  2015-10-09

9.  Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511.

Authors:  K Ohkawa; Y Tsukada; M Murae; E Kimura; K Takada; T Abe; Y Terashima; K Mitani
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

10.  Multiple epitopes of the human ovarian cancer antigen 14C1 recognised by human IgG antibodies: their potential in immunotherapy.

Authors:  G Gallagher; F al-Azzawi; L P Walsh; G Wilson; J Handley
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.